Literature DB >> 19280430

SRA and its binding partners: an expanding role for RNA-binding coregulators in nuclear receptor-mediated gene regulation.

Shane M Colley1, Peter J Leedman.   

Abstract

The discovery that SRA RNA can function as a nuclear receptor (NR) coactivator resulted in a fundamental change in the perception of how NRs and their coregulators may regulate hormone signaling pathways. The subsequent identification of molecules capable of binding SRA, including SHARP, p68, and more recently SLIRP, which also function as coregulators, has further broadened our understanding of NR-dependent gene regulation. The integral role that NRs play in directing developmental, metabolic and pathological programs of transcription has defined them as paramount targets for treating a broad range of human diseases. Thus with a greater understanding of SRA and its interactions with its binding partners, novel RNA-protein interactions may be identified and exploited for therapeutic gain. Here we discuss the isolation of SRA, its impact on NR activity and interactions with known binding partners.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280430     DOI: 10.1080/10409230802661719

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  22 in total

Review 1.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 2.  Large non-coding RNAs: missing links in cancer?

Authors:  Maite Huarte; John L Rinn
Journal:  Hum Mol Genet       Date:  2010-08-20       Impact factor: 6.150

Review 3.  Peptides encoded by noncoding genes: challenges and perspectives.

Authors:  Shuo Wang; Chuanbin Mao; Shanrong Liu
Journal:  Signal Transduct Target Ther       Date:  2019-12-13

Review 4.  Long non-coding RNAs: challenges for diagnosis and therapies.

Authors:  Yolanda Sánchez; Maite Huarte
Journal:  Nucleic Acid Ther       Date:  2013-02       Impact factor: 5.486

5.  Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene.

Authors:  Charles E Foulds; Anna Tsimelzon; Weiwen Long; Andrew Le; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2010-03-10

6.  Transcriptional regulation by small RNAs at sequences downstream from 3' gene termini.

Authors:  Xuan Yue; Jacob C Schwartz; Yongjun Chu; Scott T Younger; Keith T Gagnon; Sayda Elbashir; Bethany A Janowski; David R Corey
Journal:  Nat Chem Biol       Date:  2010-06-27       Impact factor: 15.040

7.  Mediation of CTCF transcriptional insulation by DEAD-box RNA-binding protein p68 and steroid receptor RNA activator SRA.

Authors:  Hongjie Yao; Kevin Brick; Yvonne Evrard; Tiaojiang Xiao; R Daniel Camerini-Otero; Gary Felsenfeld
Journal:  Genes Dev       Date:  2010-10-21       Impact factor: 11.361

Review 8.  'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.

Authors:  Mei S Ong; Wanpei Cai; Yi Yuan; Hin C Leong; Tuan Z Tan; Asad Mohammad; Ming L You; Frank Arfuso; Boon C Goh; Sudha Warrier; Gautam Sethi; Nicholas S Tolwinski; Peter E Lobie; Celestial T Yap; Shing C Hooi; Ruby Y Huang; Alan P Kumar
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

9.  LRPPRC and SLIRP interact in a ribonucleoprotein complex that regulates posttranscriptional gene expression in mitochondria.

Authors:  Florin Sasarman; Catherine Brunel-Guitton; Hana Antonicka; Timothy Wai; Eric A Shoubridge
Journal:  Mol Biol Cell       Date:  2010-03-03       Impact factor: 4.138

10.  Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes.

Authors:  Guillermo Pablo Vicent; A Silvina Nacht; Roser Zaurin; Jofre Font-Mateu; Daniel Soronellas; Francois Le Dily; Diana Reyes; Miguel Beato
Journal:  Genes Dev       Date:  2013-05-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.